BCL2 and cancer: Treatment with FKB+doxorubicin increased the ratio of Beclin-1/Bcl-2, and the ratio of Bax/Bcl-2 in AGS cancer cells indicates that FKB+doxorubicin can increase cell death through pro-apoptotic signaling.